on-demand webinar

Digital Evidence Generation: FDA Perspectives on Computer Simulations in the Evaluation of Medical Devices

Share

Digital Evidence Generation: FDA Perspectives on Computer Simulations in the Evaluation of Medical Devices

FDA acknowledges the benefits to public health provided by modeling and simulation, and routinely advises the medical device industry on the use of simulation methodologies so that safe and effective new therapeutics can advance more efficiently, from design to preclinical studies through clinical trials to market.

In this webinar, FDA’s Dr. Tina Morrison, Deputy Director, Division of Applied Mechanics, Center for Devices and Radiological Health, U.S. Food and Drug Administration, provides an overview of those methodologies and highlights the possibility for in silico clinical trials to be used for evaluating medical products.